SCHEMBL5221801

SCHEMBL5221801

C[SiH](C)OC(c1ccc(-c2ccc(CI)cc2)cc1)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5973112 0.79 TRPA1 (0.30)
SCHEMBL5979923 0.79 PPARG (0.37)
SCHEMBL6615169 0.79
SCHEMBL4729097 0.77 ALDH1A1 (0.38)
SCHEMBL7277057 0.76
SCHEMBL11086988 0.74
SCHEMBL17111856 0.74 RXRA (0.41)
SCHEMBL507894 0.73 CYP1A2 (0.33)
SCHEMBL7262932 0.73
SCHEMBL2298491 0.73 ESR1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1227721-B1 NOVEL SUBSTITUTED SUCCINIC ACID METALLO-BETA-LACTAMASE INHIBITORS AND THEIR USE IN TREATING BACTERIAL INFECTIONS MERCK & CO INC (US) 2007-04-04 EP disclosed
US-20030207859-A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections BALKOVEC JAMES M (US) 2003-11-06 US disclosed
US-6630510-B1 Together with a beta-lactam antibiotic MERCK & CO., INC. 2003-10-07 US disclosed
US-20030078418-A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections BALKOVEC JAMES M (US) 2003-04-24 US disclosed